TrialCNS drugs2017

Long-Term Safety and Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents with ADHD: A Phase IV, 2-Year, Open-Label Study in Europe.

David R Coghill et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.